Advertisement

Archive

2017: Issue 6 2017 (pp. 1007-1216)

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

20 articles
1.

P. S. Loewen (1), A. T. Ji (1), A. Kapanen (1), A. McClean (1)

(1) Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada

Thromb Haemost 2017 117 6: 1007-1022

https://doi.org/10.1160/TH16-10-0787

[Summary] [Free PDF] [Export citation]
2.

Online Supplementary Material

A. Iorio (1), K. Fischer (2), V. Blanchette (3), S. Rangarajan (4), G. Young (5), M. Morfini (6), for the Pharmacokinetic (PK) Expert Working Group of the International Prophylaxis Study Group (the IPSG)

(1) Department of Health Research Methods, Evidence, and Impact and Department of Medicine, McMaster University, Hamilton, Ontario, Canada; (2) Van Creveldkliniek, University Medical Center, Utrecht, The Netherlands; (3) Division of Hematology/Oncology, Hospital for Sick Children and Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; (4) Haemophilia, Haemostasis & Thrombosis Centre Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK; (5) Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California, California, USA; (6) Italian Association of Haemophilia Centres (AICE), Florence, Italy

Thromb Haemost 2017 117 6: 1023-1030

https://doi.org/10.1160/TH16-12-0942

[Summary] [Free PDF] [Export citation]
3.
Open Access

N. Luan (1), C. Zhou (1), P. Li (1), R. Ombati (2, 3, 4), X. Yan (1), G. Mo (1), M. Rong (3), R. Lai (2, 1, 3), Z. Duan (2, 3), R. Zheng (5)

(1) Key Laboratory of Microbiological Engineering of Agricultural Environment, Ministry of Agriculture, College of Life Sciences, Nanjing Agricultural University, Nanjing, Jiangsu, China; (2) University of Chinese Academy of Sciences, Beijing, China; (3) Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China; (4) Sino-African Joint Research Center, CAS, Kunming Institute of Zoology, Kunming, Yunnan, China; (5) Intensive Care Unit, Subei People’s Hospital of Jiangsu Province, Yangzhou, Jiangsu, China

Thromb Haemost 2017 117 6: 1031-1039

https://doi.org/10.1160/TH16-11-0829

[Summary] [Free PDF] [Export citation]
4.

Online Supplementary Material

M. Alhenc-Gelas, G. Plu-Bureau, J. Hugon-Rodin, V. Picard, M.-H. Horellou, GFHT study group on Genetic Thrombophilia

Thromb Haemost 2017 117 6: 1040-1051

https://doi.org/10.1160/TH16-08-0635

[Summary] [PDF] [Pay per view] [Export citation]
5.

B. Hua (1), R. Wu (2), F. Sun (3), B. Luo (4), C. Alvey (5), R. Labadie (5), P. R. Qu (4), J. M. Korth-Bradley (6), P. Rendo (6)

(1) Peking Union Medical College Hospital (PUMCH), Department of Haematology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; (2) Beijing Children’s Hospital, Haematology Department, Capital Medical University, Beijing, China; (3) Pfizer Inc, Beijing, China; (4) Pfizer Inc, Shanghai, China; (5) Pfizer Inc, Groton, Conneticut, USA; (6) Pfizer Inc, Collegeville, Pennsylvania, USA

Thromb Haemost 2017 117 6: 1052-1057

https://doi.org/10.1160/TH16-10-0765

[Summary] [PDF] [Pay per view] [Export citation]
6.

V. A. Miller (1), P. A. Madureira (2), A. A. Kamaludin (3), J. Komar (3), V. Sharma (4), G. Sahni (4), C. Thelwell (5), C. Longstaff (5), D. M. Waisman (1, 3)

(1) Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada; (2) Centre for Biomedical Research (CBMR), University of Algarve, Campus of Gambelas, Faro, Portugal; (3) Department of Biochemistry & Molecular Biology, Dalhousie University, Halifax, Nova Scotia, Canada; (4) Institute of Microbial Technology (C. S. I.R), Sector 39-A, Chandigarh, India; (5) Haemostasis Section, Biotherapeutics Group, National Institute for Biological Standards and Control, South Mimms, Herts, UK

Thromb Haemost 2017 117 6: 1058-1071

https://doi.org/10.1160/TH16-12-0936

[Summary] [PDF] [Pay per view] [Export citation]
7.
Open Access

Online Supplementary Material

X. Li (1), S. Deitelzweig (2), A. Keshishian (3), M. Hamilton (1), R. Horblyuk (4), K. Gupta (1), X. Luo (5), J. Mardekian (4), K. Friend (1), A. Nadkarni (1), X. Pan (6), G. Y. H. Lip (7, 8)

(1) Bristol-Myers Squibb Company, Lawrenceville, New Jersey, USA; (2) Ochsner Clinic Foundation, Department of Hospital Medicine, New Orleans, Louisianna, USA and The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, Louisianna, USA; (3) STATinMED Research, Ann Arbor, Michigan, USA; (4) Pfizer, Inc., New York, New York, USA; (5) Pfizer, Inc., Groton, Conneticut, USA; (6) Bristol-Myers Squibb Company, Wallingford, Conneticut, USA; (7) Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK; (8) Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Thromb Haemost 2017 117 6: 1072-1082

https://doi.org/10.1160/TH17-01-0068

[Summary] [Free PDF] [Export citation]
8.

Online Supplementary Material

J. D. Eicher (1, 2), M.-H. Chen (1, 2), A. N. Pitsillides (2), H. Lin (3), N. Veeraraghavan (4), J. A. Brody (5), G. A. Metcalf (6), D. M. Muzny (6), R. A. Gibbs (6), D. M. Becker (7), L. C. Becker (7, 8), N. Faraday (9), R. A. Mathias (10), L. R. Yanek (7), E. Boerwinkle (6, 7), L. A. Cupples (2, 8), A. D. Johnson (1, 2)

(1) Population Sciences Branch, National Heart, Lung, Blood Institute, National Institutes of Health, Framingham, Massachusetts, USA; (2) The Framingham Heart Study, Framingham, Massachusetts, USA; (3) Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA; (4) Rady Children’s Institute for Genomic Medicine, San Diego, California, USA; (5) Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA; (6) Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA; (7) GeneSTAR Research Program, Department of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; (8) GeneSTAR Research Program, Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; (9) GeneSTAR Research Program, Department of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; (10) GeneSTAR Research Program, Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Thromb Haemost 2017 117 6: 1083-1092

https://doi.org/10.1160/TH16-09-0677

[Summary] [PDF] [Pay per view] [Export citation]
9.

W. A. Parker (1), D. L. Bhatt (2), J. Prats (3), J. R. S. Day (4), P. G. Steg (5, 6), G. W. Stone (7), C. W. Hamm (8), K. W. Mahaffey (9), M. J. Price (10), C. M. Gibson (11), H. D. White (12), R. F. Storey (1), on behalf of the CHAMPION PHOENIX Investigators

(1) University of Sheffield, Sheffield, UK; (2) Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts, USA; (3) The Medicines Company, Parsippany, New Jersey, USA; (4) AstraZeneca, Luton, UK; (5) FACT (French Alliance for Cardiovascular clinical Trials), DHU FIRE, INSERM Unité 1148, Université Paris-Diderot, and Hôpital Bichat, Assistance-Publique–Hôpitaux de Paris, Paris, France; (6) NHLI, Imperial College, Royal Brompton Hospital, London, UK; (7) Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, New York, USA; (8) Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany; (9) Stanford Center for Clinical Research (SCCR), Department of Medicine, Stanford University School of Medicine, Stanford, California, USA; (10) Scripps Clinic and Scripps Translational Science Institute, La Jolla, California, USA; (11) Beth Israel Deaconess Medical Center, Division of Cardiology, Boston, Massachusetts, USA; (12) Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand

Thromb Haemost 2017 117 6: 1093-1100

https://doi.org/10.1160/TH16-12-0958

[Summary] [PDF] [Pay per view] [Export citation]
10.

Online Supplementary Material

L. Alberio (1, 2), C. Ravanat (1), B. Hechler (1), P. H. Mangin (1), F. Lanza (1), C. Gachet (1)

(1) UMR S949 INSERM, Établissement Français du Sang Grand Est, University of Strasbourg, Strasbourg, France; (2) Division of Hematology and Central Hematology Laboratory, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland

Thromb Haemost 2017 117 6: 1101-1114

https://doi.org/10.1160/TH16-09-0711

[Summary] [PDF] [Pay per view] [Export citation]
11.
Open Access

C. Barale (1, 2), S. Buracco (2), F. Cavalot (1, 2), C. Frascaroli (1, 2), A. Guerrasio (1, 2), I. Russo (1, 2)

(1) Internal Medicine and Metabolic Disease Unit, San Luigi Gonzaga Hospital, Turin, Italy; (2) Department of Clinical and Biological Sciences of the Turin University, Turin, Italy

Thromb Haemost 2017 117 6: 1115-1128

https://doi.org/10.1160/TH16-07-0586

[Summary] [Free PDF] [Export citation]
12.

M. Bonaccio (1), A. Di Castelnuovo (1), S. Costanzo (1), A. de Curtis (1), M. Persichillo (1), C. Cerletti (1), M. B. Donati (1), G. de Gaetano (1), L. Iacoviello (1, 2), on behalf of the MOLI-SANI study Investigators

(1) Department of Epidemiology and Prevention, IRCCS Istituto Neurologico Mediterraneo NEUROMED, Pozzilli (IS), Italy; (2) Department of Medicine and Surgery, University of Insubria, Varese, Italy

Thromb Haemost 2017 117 6: 1129-1140

https://doi.org/10.1160/TH16-12-0974

[Summary] [PDF] [Pay per view] [Export citation]
13.

Online Supplementary Material

L. Tarancon-Diez (1, 2), R. S. De Pablo-Bernal (1, 2), A. I. Álvarez-Rios (1, 2), I. Rosado-Sánchez (1, 2), B. Dominguez-Molina (1, 2), M. Genebat (1, 2), Y. M. Pacheco (1, 2), J. L. Jiménez (3, 4), M. Á. Muñoz-Fernández (3, 4), E. Ruiz-Mateos (1, 2), M. Leal (1, 2)

(1) Laboratory of Immunovirology, Biomedicine Institute of Seville, Virgen del Rocío University Hospital, IBIS/CSIC/SAS/University of Seville, Seville, Spain; (2) Biochemistry Department, Virgen del Rocío University Hospital, Seville, Spain; (3) Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Health Research Institute Gregorio Marañon, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; (4) Viral and Immune Infection Unit Center, Institute of Health Carlos III, Majadahonda Campus, Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Madrid, Spain

Thromb Haemost 2017 117 6: 1141-1149

https://doi.org/10.1160/TH16-11-0867

[Summary] [PDF] [Pay per view] [Export citation]
14.

Online Supplementary Material

A. Klotzsche – von Ameln (1), S. Cremer (2), J. Hoffmann (2), P. Schuster (3), S. Khedr (4), I. Korovina (1), M. Troullinaki (1), A. Neuwirth (1), D. Sprott (1), A. Chatzigeorgiou (1), M. Economopoulou (5, 6), A. Orlandi (3), A. Hain (3), A. M. Zeiher (2, 7), A. Deussen (4), G. Hajishengallis (8), S. Dimmeler (3, 7), T. Chavakis (1, 6), E. Chavakis (2, 3, 7)

(1) Department of Clinical Pathobiochemistry, Medical Faculty, Technische Universität Dresden, Dresden, Germany; (2) Department of Internal Medicine III, Cardiology; (3) Institute of Cardiovascular Regeneration, Goethe University Frankfurt, Germany; (4) Institute of Physiology, Medical Faculty, Technische Universität Dresden, Dresden, Germany; (5) Department of Ophthalmology, Technische Universität Dresden, Dresden, Germany; (6) DFG-Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany; (7) German Center of Cardiovascular Research (DZHK), RheinMain Partner Site, Frankfurt, Germany; (8) Department of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Thromb Haemost 2017 117 6: 1150-1163

https://doi.org/10.1160/TH16-05-0354

[Summary] [PDF] [Pay per view] [Export citation]
15.

Online Supplementary Material

F. A. Klok (1), S. Barco (1), S. V. Konstantinides (1)

(1) Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Thromb Haemost 2017 117 6: 1164-1170

https://doi.org/10.1160/TH16-10-0810

[Summary] [PDF] [Pay per view] [Export citation]
16.

D. L. Culmer (1), M. L. Dunbar (2), A. E Hawley (3), S. Sood (4), R. E. Sigler (5), P. K. Henke (3), T. W. Wakefield (3), J. L. Magnani (6), D. D. Myers Jr (3, 5)

(1) Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; (2) Research Animal Resources, University of Minnesota, Minneapolis, Minnesota, USA; (3) Department of Surgery, Vascular Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA; (4) Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA; (5) Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA; (6) GlycoMimetics Inc., Rockville, Maryland, USA

Thromb Haemost 2017 117 6: 1171-1181

https://doi.org/10.1160/TH16-04-0323

[Summary] [PDF] [Pay per view] [Export citation]
17.

Online Supplementary Material

C. Sindet-Pedersen (1, 2), J. Langtved Pallisgaard (1, 2), L. Staerk (1, 2), T. A. Gerds (3, 4), E. L. Fosbøl (1, 3, 5), C. Torp-Pedersen (1, 6), G. Gislason (1, 3, 2, 7), J. B. Olesen (1)

(1) Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark; (2) Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; (3) The Danish Heart Foundation, Copenhagen, Denmark; (4) Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark; (5) Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; (6) Institute of Health, Science and Technology, Aalborg University, Aalborg, Denmark; (7) The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark

Thromb Haemost 2017 117 6: 1182-1191

https://doi.org/10.1160/TH16-10-0745

[Summary] [PDF] [Pay per view] [Export citation]
18.
Predictors of active cancer thromboembolic outcomes
RIETE experience of the Khorana score in cancer-associated thrombosis

A. J. Tafur (1), J. A. Caprini (1), L. Cote (1), J. Trujillo-Santos (2), J. Del Toro (3), F. Garcia-Bragado (4), C. Tolosa (5), G. Barillari (6), A. Visona (7), M. Monreal (8), on behalf of the RIETE Investigators

(1) NorthShore University Health Systems, Evanston, Illinois, USA; (2) Department of Internal Medicine, Hospital General Universitario Santa Lucia, Murcia, Spain; (3) Department of Internal Medicine, Hospital General Universitario Gregorio Maranon, Madrid, Spain; (4) Department of Internal Medicine, Hospital Universitari de Girona Dr Josep Trueta, Gerona, Spain; (5) Department of Internal Medicine, Corporación Sanitaria Parc Tauli, Barcelona, Spain; (6) Department of Internal Medicine, Ospedale S.Maria della Misericordia, Udine, Italy; (7) Department of Vascular Medicine, Ospedale Castelfranco Veneto, Castelfranco Veneto, Italy; (8) Department of Internal Medicine, Hospital de Badalona Germans Trias i Pujol, Universidad Católica de Murcia, Spain

Thromb Haemost 2017 117 6: 1192-1198

https://doi.org/10.1160/TH16-11-0840

[Summary] [PDF] [Pay per view] [Export citation]
19.

M. Rajpurkar (1), T. Biss (2), E. K. Amankwah (3, 4), D. Martinez (4), S. Williams (5), C. H. Van Ommen (6), N. A. Goldenberg (4, 7)

(1) The Carman and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Wayne State University School of Medicine, Children’s Hospital of Michigan, Detroit, Michigan, USA; (2) Department of Haematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; (3) Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; (4) Clinical and Translational Research Organization, Johns Hopkins All Children’s Hospital, St. Petersburg, Florida, USA; (5) Division of Haematology/Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto & University of Toronto,Toronto, Ontario, Canada; (6) Department of Pediatric Hematology, Erasmus Medical Center Sophia Children’s Hospital, Rotterdam, the Netherlands; (7) Division of Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine and Johns Hopkins Medicine Pediatric Thrombosis Program, St. Petersburg, Florida and Baltimore, Maryland, USA

Thromb Haemost 2017 117 6: 1199-1207

https://doi.org/10.1160/TH16-07-0529

[Summary] [PDF] [Pay per view] [Export citation]
20.
Open Access

Online Supplementary Material

G. Campo (1, 2), F. Vieceli Dalla Sega (2, 3), R. Pavasini (1), G. Aquila (2, 3), F. Gallo (1), F. Fortini (2, 3), E. Tonet (1), P. Cimaglia (1), A. Del Franco (1), G. Pestelli (1), A. Pecoraro (1), M. Contoli (4), C. Balla (1), S. Biscaglia (1), P. Rizzo (5), R. Ferrari (1, 2, 6)

(1) Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona (FE), Italy; (2) Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA) Center, Ferrara, Italy; (3) Department of Medical Sciences, University of Ferrara, Ferrara, Italy; (4) Research Centre on Asthma and COPD, Section of Internal and Cardio-Respiratory Medicine, University of Ferrara, Ferrara, Italy; (5) Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy; (6) Maria Cecilia Hospital, GVM Care & Research, E. S.: Health Science Foundation, Cotignola, Italy

Thromb Haemost 2017 117 6: 1208-1216

https://doi.org/10.1160/TH16-12-0973

[Summary] [Free PDF] [Export citation]